Literature DB >> 9160102

The amino acid sequence of the glycosylated amyloid immunoglobulin light chain protein AL MS.

L A Omtvedt1, G Husby, G G Cornwell, R A Kyle, K Sletten.   

Abstract

The authors report on the amino acid sequence of the glycosylated amyloid protein AL MS. The amyloid fibrils were extracted from the spleen of a patient (MS.) with amyloidosis. The protein AL MS was purified from the amyloid fibrils by gel filtration. SDS-PAGE performed on the purified protein material showed glycosylated protein bands in the range of 22 to 32 kDa, corresponding to polymerization of N-terminal fragments. The protein was characterized by amino acid analysis and Edman degradation. Tryptic digest combined with Staphylococcal V8 protease, chymotrypsin and pyroglutamate aminopeptidase digestion, as well as cleavage with BNPS-skatole, established the complete amino acid sequence of 168 residues. The protein was compared to other proteins in the SWISSPROT databank, showing homology with the immunoglobulin light chain variable subgroup lamda I. AL MS showed some unique amino acid substitutions. Highly conserved residues Gly(57) and Arg(61), were exchanged to arginine and glutamine, respectively, possibly altering the three- dimensional structure of the protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9160102     DOI: 10.1046/j.1365-3083.1997.d01-431.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  2 in total

1.  Light chain amyloidosis - current findings and future prospects.

Authors:  Elizabeth M Baden; Laura A Sikkink; Marina Ramirez-Alvarado
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

2.  IgA nephropathy caused by unusual polymerization of IgA1 with aberrant N-glycosylation in a patient with monoclonal immunoglobulin deposition disease.

Authors:  Yoshiki Narimatsu; Atsushi Kuno; Hiromi Ito; Hiroyuki Kaji; Syuzo Kaneko; Joichi Usui; Kunihiro Yamagata; Hisashi Narimatsu
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.